Maureen Testoni Named 340B Health President and CEO
WASHINGTON, D.C.— The 340B Health Board of Directors has named Maureen Testoni as the 340B Health President and CEO, effective immediately. Maureen assumes the role on a permanent basis after serving as the interim president and CEO since April 1, 2018.
Maureen had seven years of experience at 340B Health before becoming its interim leader, most recently overseeing the organization’s Legal, Policy, and Government Affairs Division. As one of the nation’s leading experts on the 340B drug pricing program, Ms. Testoni recently was recognized as one of the “100 Most Influential People in Healthcare” by Modern Healthcare. Since taking on the leadership of 340B Health on an interim basis, she has guided the organization through numerous legislative, administrative, and legal successes.
“Maureen Testoni is a dedicated, passionate, and proven leader who will skillfully serve the members of 340B Health as well as our partners in the 340B field,” said Sam Ross, MD, the chief community health officer for Bon Secours Mercy Health, president of Bon Secours Baltimore Health System, and chair of the 340B Health Board of Directors. “We look forward to her continued accomplishments for the benefit of safety-net health providers and their patients.”
Contact: Richard Sorian at email@example.com or 202-536-2285.